Inulin-enriched pasta improves intestinal permeability and modifies the circulating levels of zonulin and glucagon-like peptide 2 in healthy young volunteers

被引:73
|
作者
Russo, Francesco [1 ]
Linsalata, Michele [1 ]
Clemente, Caterina [1 ]
Chiloiro, Marisa [2 ]
Orlando, Antonella [1 ]
Marconi, Emanuele [3 ]
Chimienti, Guglielmina [4 ]
Riezzo, Giuseppe [2 ]
机构
[1] Natl Inst Digest Dis IRCCS Saverio de Bellis, Lab Expt Biochem, Bari, Italy
[2] Natl Inst Digest Dis IRCCS Saverio de Bellis, Lab Expt Pathophysiol, Bari, Italy
[3] Univ Molise, DiSTAAM, Campobasso, Italy
[4] Univ Bari, Dept Biochem & Mol Biol, Bari, Italy
关键词
Glucagon-like peptide 2; Intestinal permeability; Inulin; Randomized double-blind crossover study; Zonulin; Human; IRRITABLE-BOWEL-SYNDROME; FATTY LIVER-DISEASE; GUT MICROBIOTA; EPITHELIAL BARRIER; GROWTH-FACTOR; OBESE MICE; OLIGOFRUCTOSE; DIET; PATHOGENESIS; OVERWEIGHT;
D O I
10.1016/j.nutres.2012.09.010
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Apart from the intestinal environment, inulin induces physiological effects, which includes a reduction in glucose and lipid concentrations and modulation of gastrointestinal motility through the release of different peptides. We hypothesized that inulin-enriched pasta may also improve small intestine permeability in relation to zonulin and glucagon-like peptide 2 (GLP-2) levels in healthy young subjects. Twenty healthy, young male volunteers completed a randomized, double-blind crossover study consisting of a 2-week run-in period and two 5-week study periods (11% inulin-enriched or control pasta), with an 8-week washout period in between. The intestinal barrier function was assessed by lactulose-mannitol excretion in urine. Zonulin values and GLP-2 release were evaluated by enzyme-linked immunosorbent assay. In the inulin group, the urinary lactulose recovery was significantly lower than the other 2 groups. There were no significant differences in urinary mannitol levels between groups. Accordingly, the lactulose-mannitol excretion ratio was significantly decreased in the inulin-enriched pasta group compared with the other 2 groups. The inulin-enriched pasta group had significantly lower zonulin serum values and significantly higher GLP-2 basal values when compared with the baseline and control pasta groups. The dietary use of inulin-enriched pasta preserves intestinal mucosal barrier functioning and modulates circulating levels of zonulin and GLP-2, suggesting that prebiotics could be used in the prevention of gastrointestinal diseases and metabolic disorders. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:940 / 946
页数:7
相关论文
共 50 条
  • [41] Influence of glucagon-like peptide-2 on intestinal barrier function and immune function and changes in TGF-β1 levels in obstructive jaundice model rats
    Gan, Lihong
    Yao, Ling
    Deng, Feng
    Zheng, Li
    Zeng, Zhiping
    Li, Bing
    Fang, Nian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (05): : 3330 - 3336
  • [42] Circulating levels of endothelial progenitor cells are associated with better cognitive function in older adults with glucagon-like peptide 1 receptor agonist-treated type 2 diabetes
    Longo, Miriam
    Di Meo, Irene
    Caruso, Paola
    Muscio, Maria Francesca
    Scappaticcio, Lorenzo
    Maio, Antonietta
    Maiorino, Maria Ida
    Bellastella, Giuseppe
    Signoriello, Giuseppe
    Knop, Filip K.
    Rizzo, Maria Rosaria
    Esposito, Katherine
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 200
  • [43] The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients
    Anne Flint
    Christoph Kapitza
    Charlotte Hindsberger
    Milan Zdravkovic
    Advances in Therapy, 2011, 28 : 213 - 226
  • [44] The Once-Daily Human Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Improves Postprandial Glucose Levels in Type 2 Diabetes Patients
    Flint, Anne
    Kapitza, Christoph
    Hindsberger, Charlotte
    Zdravkovic, Milan
    ADVANCES IN THERAPY, 2011, 28 (03) : 213 - 226
  • [45] Population Pharmacokinetics of Liraglutide, a Once-Daily Human Glucagon-Like Peptide-1 Analog, in Healthy Volunteers and Subjects With Type 2 Diabetes, and Comparison to Twice-Daily Exenatide
    Watson, Estelle
    Jonker, Daniel M.
    Jacobsen, Lisbeth V.
    Ingwersen, Steen H.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (08): : 886 - 894
  • [46] GLEPAGLUTIDE, A LONG-ACTING GLUCAGON-LIKE PEPTIDE-2 ANALOG, IMPROVES INTESTINAL ABSORPTION OF MACRONUTRIENTS, BODY WEIGHT AND LEAN BODY MASS IN PATIENTS WITH SHORT BOWEL SYNDROME
    Hvistendahl, Mark
    Naimi, Rahim M.
    Hansen, Mark B.
    Jeppesen, Palle B.
    GASTROENTEROLOGY, 2018, 154 (06) : S1359 - S1360
  • [47] Roux-en-Y gastric bypass is associated with elevated levels of glucagon-like peptide 2 (GLP-2) and peptide YY (PYY) in human subjects and with proliferation of the intestinal mucosa in a rodent model.
    Borg, Cynthia-Michelle
    Le Roux, C. W.
    Ghatei, M. A.
    Bloom, S. R.
    Aylwin, S. J. B.
    Patel, A. G.
    OBESITY SURGERY, 2007, 17 (08) : 1053 - 1053
  • [48] Subcutaneous glucagon-like peptide 1 before meals with usual insulin doses through five days improves blood glucose levels in both type 1 and type 2 diabetes
    Dupré, J
    Behme, MT
    Hramiak, I
    McDonald, TJ
    DIABETES, 2000, 49 : A103 - A103
  • [49] HM15912, a Novel Long-Acting Glucagon-Like Peptide-2 Analog, Improves Intestinal Growth and Absorption Capacity in a Male Rat Model of Short Bowel Syndrome
    Choi, Jaehyuk
    Lee, Jinbong
    Park, Eunjin
    Kwon, Hyunjoo
    Kim, Daejin
    Bae, Sungmin
    Choi, In Young
    Kim, Ha Hyung
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 384 (02): : 277 - 286
  • [50] Glucagon-Like Peptide-2 Increases Insulin-Like Growth Factor-1 mRNA Transcript Levels Through PI3-K/AKT in Murine Intestinal Subepithelial Myofibroblasts
    Leen, Jason
    Upadhyay, Chandani
    Brubaker, Patricia L.
    GASTROENTEROLOGY, 2009, 136 (05) : A236 - A236